Nuove specialità medicinali disponibili nelle farmacie e parafarmacie, da Benagol, Efferalgan, e Voltadvance, oltre a 13 nuovi farmaci equivalenti
Nuove specialità medicinali disponibili nelle farmacie e parafarmacie, da Benagol, Efferalgan, e Voltadvance, oltre a 13 nuovi farmaci equivalenti.
Nuove specialità medicinali
BENAGOL 24 pastiglie menta fredda diclorofenilcarbinolo/amilmetacresolo/mentolo
RECKITT BENCKISER AIC:016242291 – C/OTC in commercio dal:01/11/2024
EFFERALGAN 30 cpr riv 500 mg paracetamolo
UPSA AIC:026608289 – C/ SOP in commercio dal:01/11/2024
VOLTADVANCE 30 cpr riv 25 mg diclofenac sodico
HALEON AIC:035500091 – C/OTC in commercio dal:01/11/2024
Nuovi farmaci equivalenti
LISINOPRIL GRINDEKS 30 cpr 10 mg lisinopril diidrato
AS GRINDEKS AIC:050486101 4,36 € Cnn/RR in commercio dal:01/11/2024
LISINOPRIL GRINDEKS 30 cpr 20 mg lisinopril diidrato
AS GRINDEKS AIC:050486176 5,27 € Cnn/RR in commercio dal:01/11/2024
LISINOPRIL GRINDEKS 30 cpr 5 mg lisinopril diidrato
AS GRINDEKS AIC:050486036 3,45 € Cnn/RR in commercio dal:01/11/2024
LOPERAMIDE GRINDEKS 20 cps 2 mg loperamide cloridrato
AS GRINDEKS AIC:050650062 – C/SOP in commercio dal:01/11/2024
RANOLAZINA PENSA 60 cpr 375 mg rilascio prolungato ranolazina
TOWA AIC:050956022 15,20 € A/RR in commercio dal:04/11/2024
RANOLAZINA PENSA 60 cpr 500 mg rilascio prolungato ranolazina
TOWA AIC:050956046 15,20 € A/RR in commercio dal:04/11/2024
SITAGLIPTIN GRINDEKS 28 cpr riv 100 mg sitagliptin cloridrato monoidrato
AS GRINDEKS AIC:049816073 29,61 € A/RR in commercio dal:01/11/2024
SITAGLIPTIN GRINDEKS 28 cpr riv 50 mg sitagliptin cloridrato monoidrato
AS GRINDEKS AIC:049816046 29,61 € A/RR in commercio dal:01/11/2024
SITAGLIPTIN GRINDEKS 98 cpr riv 100 mg sitagliptin cloridrato monoidrato
AS GRINDEKS AIC:049816097 93,27 € Cnn/RR in commercio dal:01/11/2024
SITAGLIPTIN GRINDEKS 98 cpr riv 50 mg sitagliptin cloridrato monoidrato
AS GRINDEKS AIC:049816061 93,27 € Cnn/RR in commercio dal:01/11/2024
TADALAFIL TEVA 8 cpr riv 20 mg tadalafil
TEVA AIC:045617545 52,00 € C/RR in commercio dal:30/10/2024
TERIFLUNOMIDE ABDI 28 cpr riv 14 mg teriflunomide
ABDI FARMA AIC:050739022 688,87 € A/RR in commercio dal:29/10/2024
TERIFLUNOMIDE ABDI 84 cpr riv 14 mg teriflunomide
ABDI FARMA AIC:050739034 2.066,61 € A/RR in commercio dal:29/10/2024